Login
$CLDX
$30.15 +$0.65 (2.2%) Close

$CLDX 3 SEC Filings

Filed On Filing
12 Nov 2025 Form 3: Lawver Teri L, SVP & Chief Commercial Officer

No securities owned

06 Jun 2025 Form 3: Torres Denice, Director

No securities owned

21 Feb 2023 Form 3: Jain Rita, Director

No securities owned

17 Jun 2022 Form 3: Cohen Cheryl, Director

No securities owned

17 Jun 2022 Form 3: Neil Garry Arthur, Director

No securities owned

04 Jan 2021 Form 3: Jimenez Freddy A., SVP & General Counsel
08 Jul 2019 Form 3: Young Diane C., SVP, Chief Medical Officer

No securities owned

03 Oct 2017 Form 3: Heath-Chiozzi Margo, SVP of of Regulatory Affairs

No securities owned

05 Jul 2017 Form 3: Martin Samuel Bates, SVP and CFO
16 Jun 2017 Form 3: Brownlie Keith L, Director

No securities owned

16 Jun 2017 Form 3: Cavanaugh Sarah, SVP of Corp. Affairs & Admin.

Holds 4,760 shares of Common Stock, par value $0.001 per share

01 Mar 2017 Form 3: Marino James J, Director

Holds 15,997 shares of Common Stock, par value $0.001 per share

15 Dec 2016 Form 3: McMahon Gerald PhD, Director

Holds 267,356 shares of Common Stock, par value $0.001 per share

05 Dec 2016 Form 3: LaVallee Theresa, SVP, Reg. & Precision Medicine

No securities owned

12 Aug 2016 Form 3: Crowley Elizabeth, SVP, Chief Product Dev Officer

Holds 7,322 shares of Common stock, par value $0.001 per share

01 Jul 2015 Form 3: Wright Richard M., Sr. VP & CCO

Holds 3,125 shares of Common stock, par value $0.001 per share

19 Dec 2014 Form 3: van den Broek Richard, Director

Holds 200,000 shares of Common stock, par value $0.001 per share

06 Jul 2011 Form 3: Pepin Ronald, Sr. VP & CBO

No securities owned

06 Oct 2009 Form 3: Shannon Timothy M, Director

Holds 66,212 shares of Common Stock, par value $.001 per share

25 Mar 2008 Form 3: Davis Thomas Andrew, Sen. VP & Ch. Medical Officer

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support